CFB
IMUX icon

Cullen/Frost Bankers’s Immunic IMUX Stock Holding History

Cullen/Frost Bankers’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13
Closed -$2K – 1210
2020
Q2 		$2K Buy
+13
New +$1.32K ﹤0.01% 1024

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cullen/Frost Bankers's IMUX Position: Q3 2020 in Review

Cullen/Frost Bankers sold out of Immunic (IMUX) in Q3 2020, closing a stake of 13 shares — an estimated $2K sold.

Cullen/Frost Bankers first reported a position in IMUX in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 66 funds tracked by Wall St. Rank hold IMUX as of Q3 2020.

  • Cullen/Frost Bankers reported no remaining Immunic position as of Q3 2020 after selling out during the quarter.
  • Cullen/Frost Bankers sold 13 Immunic shares in Q3 2020, an estimated $2K.
  • Cullen/Frost Bankers first reported a position in Immunic in Q2 2020 and held it in 1 quarter.
  • Cullen/Frost Bankers's Immunic position peaked at $2K in Q2 2020.
  • 66 funds tracked by Wall St. Rank held Immunic as of Q3 2020.

Based on Cullen/Frost Bankers's 13F filing for Q3 2020, filed 5 Nov 2020.